Indexed logomarkindexed.vc

Currus Biologics

Biotech
Therapeutics
Website
currusbio.com
Last Round
Series AJun 2021
Rounds
1

About

Currus Biologics is a Biotech company. Its most recent funding was a Series A round in Jun 2021. Investors include Brandon Capital Partners and Uniseed.

LinkedIn

Funding History

Series ASeries AJun 2021

Investors

Brandon Capital Partners

Lead

1 round

Uniseed

1 round

Similar Companies

Paratek Pharmaceuticals

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
Convertible·$1.8B·Apr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series D·$1.4B·Jun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension Round·$1.2B·Nov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$884.0M·Jul 2025

Appears in

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Currus Biologics on Indexed.vc
<a href="https://indexed.vc/companies/currus-biologics"><img src="https://indexed.vc/api/badge/company/currus-biologics" alt="Currus Biologics on Indexed.vc" width="260" height="76" /></a>